Medicines used in the Treatment of Neurodisorders
The drugs used in the treatment of neurodisoders are mostly Cholinesterase inhibitors. Now a days botulinum toxin has been used widely for the cure. Dopamine induced drugs to be consumed. Guanidine derivatives are used to prevent the neurodegenerative disorders.
- Rituximab
- Donepezil
- Ethosuximide
- Clonazepam
Related Conference of Medicines used in the Treatment of Neurodisorders
August 13-14, 2018
31st Clinical Neuroscience and Neurogenetics Conference: Mobilizing Neurons to Rehabilitate
Dubai, UAE
August 16-17, 2018
3rd International Congress on Addictive Behavior & Dual Diagnosis
Stockholm, Sweden
August 27-28, 2018
8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry
Tokyo, Japan
August 31-September 01, 2018
6th World Summit on Heart, Stroke & Neurological Disorders
Heart, Stroke & Neurological Disorders
Boston, Massachusetts, USA
August 31-September 01, 2018
14th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness
Boston, Massachusetts, USA
September 13-15, 2018
6th International Conference on Brain Disorders and Therapeutics
Copenhagen, Denmark
September 17-18, 2018
25th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Dubai, UAE
September 20-21, 2018
8th International Congress on Stroke and Brain Hemorrhage
Prague | Czech Republic
September 21-22, 2018
8th International Conference on Neurology and Brain Disorders
Philadelphia, Pennsylvania, USA
September 21-22, 2018
3rd International Conference on Neuropsychiatry and Sleep Medicine
Philadelphia, Pennsylvania, USA
September 26-27, 2018
International Conference on Neuroimmunology, Neurological disorders and Neurogenetics
Montreal, Canada
September 26-27, 2018
28th World Summit on Neurology, Neuroscience and Neuropharmacology
Montreal, Quebec, Canada
October 03-04, 2018
3rd International conference on Neuroscience, Neuroradiology & Imaging
Osaka, Japan
October 18-19, 2018
27th International Conference on Neurology and Cognitive Neuroscience
Warsaw, Poland
October 18-19, 2018
Neurodegenerative and Neuroinflammation Conference: From Discovery to Health
Helsinki, Finland
October 19-20, 2018
5th International Conference on Parkinson’s disease and Movement Disorders
New York, USA
November 5-7, 2018
International Conference on Bipolar Disorder: Psychiatry and Mental Health
Abu Dhabi, UAE
November 12-13, 2018
4th International Conference on Central Nervous System Disorders & Therapeutics
Edinburgh, Scotland
November 12-13, 2018
30th International Conference on Mental and Behavioral Health
Melbourne, Australia
December 5-6, 2018
26th International Conference on Psychiatric Disorders & Psychosomatic Medicine
Dubai, UAE
March 18-20, 2019
24th International Conference on Neurosurgery and Neuroscience
Edinburgh, Scotland
March 25-26, 2019
International Conference & Exhibition on Addictive Disorders & Addiction Therapy
Yokohama, Japan
April 22-23, 2019
15th International Conference and Exhibition on Alzheimer’s Disease, Dementia & Aging
| Rome | Italy
May 08-09, 2019
5th Global Experts Meeting on Parkinsons, Huntingtons & Movement Disorders
Tokyo, Japan
June 17-18, 2019
9th International Conference on Addictive Disorders and Alcoholism
Brisbane, Australia
Medicines used in the Treatment of Neurodisorders Conference Speakers
Recommended Sessions
- Neuromuscular Disorder and Peripheral Neuropathies
- Role of Medications and Trans cranial Magnetic Radiations in Neuroscience
- "just a headache" - The Migraine Trust
- Advances in Prevention, Treatment ,Recovery and Novel Therapies in Neuroscience
- Advancing the “Next-Generation” of Brain Research
- Alzheimer ’s disease
- American Psychological Association
- American Academy of Neurology
- Neurology & Neurological Sciences
- Case Report
- Chronic Neuro Disorders
- CNS
- Conferences and Meetings on Neurology
- Dementia and Mild Cognitive Impairment
- European Neurology Congress
- Geriatric Neurology
- Medicines used in the Treatment of Neurodisorders
- Mental Health Nursing
- Molecular , Clinical and Behavioral Neuroscience
- Multiple Sclerosis
- Nervous System Diseases
- Nervous System Diseases-Medline Plus
- Neural Coding
- Neuro Pharmacology and Neuro Toxicology
- Neurological Institute
- Neurologist
- Neurology Conferences
- Neuromuscular Disorders , Spinal disorders and Peripheral Neuropathies
- Neurons and Neurology
- Neuropathy and Neuropathology
- NeuroRehabilitation
- Neurosurgery
- Novel therapies in Neuroscience
- Parkinson’s disease
- Pediatric Neurology
- Psychiatry and Mental Health
- Psychology
- Society for Neuro-Oncology
- Stroke
- Stroke
- Tourette Syndrome
- Trigeminal Neuralgia
- Trigeminal Neuralgia
- Vertigo
Related Journals
Are you interested in
- Addiction & Psychopharmacology - Neurochemistry 2018 (UK)
- Advances in Neurological Disorders - Neurochemistry 2018 (UK)
- Central Nervous System Disorders - Neurochemistry 2018 (UK)
- Clinical Neurochemistry - Neurochemistry 2018 (UK)
- Clinical Neurochemistry - Neurochemistry 2018 (UK)
- N-methyl D-aspartate receptor (NMDA receptor) - Neurochemistry 2018 (UK)
- Nanotechnology in Neurochemistry - Neurochemistry 2018 (UK)
- Neural Stem Cells - Neurochemistry 2018 (UK)
- Neuro Plasticity - Neurochemistry 2018 (UK)
- Neuro-Ophthalmology - Neurochemistry 2018 (UK)
- Neuro-stimulants - Neurochemistry 2018 (UK)
- Neurochemistry - Neurochemistry 2018 (UK)
- Neuroethics and Neuroscience - Neurochemistry 2018 (UK)
- Neurogenesis & Neurotransmission - Neurochemistry 2018 (UK)
- Neuroimmunology and Neuropathology - Neurochemistry 2018 (UK)
- Neuroinflamation - Neurochemistry 2018 (UK)
- Neuropharmacology - Neurochemistry 2018 (UK)
- Neuroscience and Neurological Disorders - Neurochemistry 2018 (UK)
- Novel Diagnostic and Therapeutic advances - Neurochemistry 2018 (UK)
- Psychiatric Disorders and Behavioral Therapy - Neurochemistry 2018 (UK)